Cybin announces us$30m common stock purchase agreement from lincoln park capital fund

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american: cybn) (“cybin” or the “company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce that it has entered into a common share purchase agreement (the “agreement”) with lincoln park capital fund, llc (“lpc”), an institutional investor. subject to the terms and conditions of the agreement, cybin has the r.
CYBN Ratings Summary
CYBN Quant Ranking